TORRENT PHARM - stock earnings
TORNTPHARM.NS Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | 4.4 billion INR | 26.9 billion INR |
| 2023Q3 | 3.9 billion INR | 26.3 billion INR |
| 2023Q2 | 3.8 billion INR | 25.5 billion INR |
| 2023Q1 | 3.0 billion INR | 24.5 billion INR |
| 2022Q4 | 2.8 billion INR | 24.6 billion INR |
| 2022Q3 | 3.1 billion INR | 22.6 billion INR |
| 2022Q2 | 3.5 billion INR | 22.9 billion INR |
| 2022Q1 | 3.8 billion INR | 22.9 billion INR |
| 2021Q4 | 2.5 billion INR | 20.9 billion INR |
| 2021Q3 | 3.2 billion INR | 21.0 billion INR |
| 2021Q2 | 3.3 billion INR | 21.2 billion INR |
| 2021Q1 | 3.2 billion INR | 19.2 billion INR |
| 2020Q4 | 3.0 billion INR | 19.7 billion INR |
| 2020Q3 | 3.1 billion INR | 19.9 billion INR |
| 2020Q2 | 3.2 billion INR | 20.1 billion INR |
| 2020Q1 | 3.1 billion INR | 19.1 billion INR |
| 2019Q4 | 2.5 billion INR | 19.2 billion INR |
| 2019Q3 | 2.4 billion INR | 19.7 billion INR |
| 2019Q2 | 2.2 billion INR | 19.8 billion INR |
| 2019Q1 | -1.5 billion INR | 18.2 billion INR |
| 2018Q4 | 2.5 billion INR | 19.5 billion INR |
| 2018Q3 | 1.8 billion INR | 18.6 billion INR |
| 2018Q2 | 1.6 billion INR | 18.3 billion INR |
| 2018Q1 | 2.3 billion INR | 16.8 billion INR |
| 2017Q4 | 580.0 million INR | 14.5 billion INR |
| 2017Q3 | 2.0 billion INR | 14.0 billion INR |
| 2017Q2 | 1.9 billion INR | 13.5 billion INR |
| 2017Q1 | 2.1 billion INR | 13.8 billion INR |
| 2016Q4 | 2.3 billion INR | 14.1 billion INR |
| 2016Q3 | 2.1 billion INR | 14.1 billion INR |
| 2016Q2 | 2.9 billion INR | 15.1 billion INR |
| 2016Q1 | 2.8 billion INR | 14.8 billion INR |
| 2015Q4 | 4.8 billion INR | 15.2 billion INR |
| 2015Q3 | 5.7 billion INR | 16.6 billion INR |
| 2015Q2 | 4.5 billion INR | 18.9 billion INR |
| 2015Q1 | 1.3 billion INR | 11.3 billion INR |
| 2014Q4 | 1.7 billion INR | 11.6 billion INR |
| 2014Q3 | 2.0 billion INR | 12.0 billion INR |
| 2014Q2 | 2.6 billion INR | 10.9 billion INR |
| 2014Q1 | 2.4 billion INR | 12.0 billion INR |
| 2013Q4 | 1.6 billion INR | 9.9 billion INR |
| 2013Q3 | 1.1 billion INR | 9.4 billion INR |
| 2013Q2 | 1.5 billion INR | 9.0 billion INR |
| 2013Q1 | 1.1 billion INR | 8.0 billion INR |
| 2012Q4 | 1.1 billion INR | 7.7 billion INR |
| 2012Q3 | 1.1 billion INR | 7.5 billion INR |
| 2012Q2 | 1.0 billion INR | 7.4 billion INR |
| 2012Q1 | -16.5 million INR | 6.5 billion INR |
| 2011Q4 | 831.8 million INR | 6.7 billion INR |
TORNTPHARM.NS Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 12.5 billion INR | 94.6 billion INR |
| 2022 | 7.8 billion INR | 84.2 billion INR |
| 2021 | 12.5 billion INR | 78.9 billion INR |
| 2020 | 10.2 billion INR | 77.8 billion INR |
| 2019 | 4.4 billion INR | 74.6 billion INR |
| 2018 | 6.8 billion INR | 58.6 billion INR |
| 2017 | 9.3 billion INR | 56.7 billion INR |
| 2016 | 17.2 billion INR | 65.2 billion INR |
| 2015 | 7.5 billion INR | 45.8 billion INR |
| 2014 | 6.6 billion INR | 40.3 billion INR |
| 2013 | 4.3 billion INR | 30.5 billion INR |
| 2012 | 2.8 billion INR | 25.9 billion INR |
| 2011 | 2.7 billion INR | 21.2 billion INR |
| 2010 | 2.3 billion INR | 19.2 billion INR |
| 2009 | 1.8 billion INR | 16.3 billion INR |
| 2008 | 1.3 billion INR | 13.5 billion INR |
| 2007 | 935.1 million INR | 13.0 billion INR |
| 2006 | 508.6 million INR | 9.7 billion INR |
| 2005 | 487.6 million INR | 5.5 billion INR |
TORNTPHARM.NS
Price: ₹2,698.70
Dividend Yield: 0.01%
Forward Dividend Yield: 1.63%
Payout Ratio: 99.44%
Dividend Per Share: 44.00 INR
Earnings Per Share: 44.27 INR
P/E Ratio: 60.01
Exchange: NSI
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 875.7 billion
Average Dividend Frequency: 2
Years Paying Dividends: 22
DGR3: 30.00%
DGR5: 30.00%
DGR10: 30.00%